image

The best stocks to buy since 1993

Latest issue now available

EROS -NYSE listing back on for New Year

December 2012

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • EROS
  • Price:
  • 238p
Eros has reported its first half results. The numbers themselves were less important than the fact that the company is to restart the process of listing its shares on the NYSE in the New Year. Results themselves are skewed by the 21% depreciation of the Rupee against the dollar in the past year and also the phasing of quarterly TV deals outside India, which fall into H2 this year - a similar story as at Entertainment One. As it was first half sales were $86.4m, down 6% but up 4.4% on a constant currency basis. This all served to swing adjusted pretax profit down by 45% to US$16.8m. Eps fell from 18.6 cents to 7 cents.   India accounted for sales of $62.4m, a 21% increase, boosted by two high profile internationall ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe